A Single-Center, Retrospective Study to Improve the Visibility of Breast Tissue Marker Clips in Breast Tissue and Axillary Lymph Nodes Using the Color Doppler Twinkling Artifact
A Single-Center, Retrospective Study on Enhancing the Visibility of Breast Tissue Marker Clips in Breast Tissue and Axillary Lymph Nodes Using the Twinkling Artifact Feature in Color Doppler Ultrasound
Study Overview
Status
Status
Conditions
Conditions
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Yilin Quan
- Phone Number: 15191782318
- Email: quanylin@mail2.sysu.edu.cn
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Female patients aged ≥18 years.
- Presence of suspicious breast lesions confirmed by ultrasound.
- Successful implantation of a breast tissue marker clip with accurate radiological documentation.
- Availability of preoperative breast ultrasound examinations (including B-mode and Color Doppler) performed using either a GE-10 or Siemens ultrasound system.
- Confirmation of clip placement via mammography, surgical specimen morphology, or same-day post-implantation ultrasound.
Exclusion Criteria:
- Pregnancy or lactation.
- History of ipsilateral breast malignancy or surgery.
- Presence of other metal implants potentially interfering with imaging.
- Suspicious mammographic microcalcifications in the target lesion.
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
|---|
|
Conventional Ultrasound and Twinkling Artifact Group
Patients examined using both B-mode ultrasound and color Doppler ultrasound (with twinkling artifact assessment).
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Proportion of subjects exhibiting the "Twinkling Artifact" posterior to the marker clip on Color Doppler Ultrasound.
Time Frame: From May 2026 to May2027
|
From May 2026 to May2027
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Rate of successful breast-conserving surgery.
Time Frame: From January 2026 to January 2027
|
From January 2026 to January 2027
|
|
Re-operation rate, defined as cases with negative intraoperative margins but positive cancerous margins on final postoperative pathology.
Time Frame: From January 2026 to January 2027
|
From January 2026 to January 2027
|
|
Inter-observer agreement rate in interpreting B-mode ultrasound visibility and Twinkling Artifact results among different radiologists.
Time Frame: From January 2026 to January 2027
|
From January 2026 to January 2027
|
|
Proportion of subjects in whom the marker clip appears as a "hyperechoic structure" on conventional B-mode ultrasound.
Time Frame: From January 2026 to January 2027
|
From January 2026 to January 2027
|
|
Positive margin rate.
Time Frame: From January 2026 to January 2027
|
From January 2026 to January 2027
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Study Director: Chang Gong, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Study record dates
Study Major Dates
Study Start (Estimated)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- SYSKY-2026-002-01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.